Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008 by Archer, Brett N et al.
263
ORIGINAL ARTICLES
April 2011, Vol. 101, No. 4  SAMJ
Rift Valley fever (RVF) is a viral zoonosis endemic to Africa1 that 
primarily affects domestic ruminants, causing large epizootics with 
high mortality rates in young animals and abortions.1-3 Transmission 
to humans occurs through direct contact with infected animal tissues, 
blood or other body fluids, and less commonly by mosquito bites. 
Inhalation of aerosolised infected fluids or ingestion of unpasteurised 
milk from infected animals might also be less frequent sources of 
infection.4-5 Since contact with sick animals and animal products, 
including blood, meat and milk, is the major risk factor for acquiring 
RVF, occupational groups such as farmers, slaughterhouse workers 
and veterinarians are at an increased risk of infection.4,6-8 No human-
to-human transmission has been documented.
Infection in humans is typically asymptomatic or limited to a 
mild febrile illness. Complications are rare, but may manifest as 
encephalitis (1 - 10%), hepatitis (<1%), haemorrhagic fever (<1%) 
or retinitis (<1%).5 Deaths due to RVF virus (RVFV) infections are 
rare (case fatality rate 1%).5 Long-lasting immunity follows infection, 
making RVFV a good candidate for prevention by vaccine, which 
may be expected for wider use in the near future.9 In the past, high-
risk occupational groups in South Africa could receive an unlicensed, 
inactivated whole-virus vaccine against RVF.10 However, vaccination 
of cattle and other ruminants is encouraged using licensed RVF 
vaccines for veterinary use.  
Sporadic outbreaks of RVF have been recorded in South Africa 
over the past five decades, the last major epidemic having been 
between 1974 and 1976.3-4 The 1977 RVF epidemic in Egypt resulted 
in an estimated 20 - 30% attack rate in this completely susceptible 
human population.11 Outbreaks have been reported in sub-Saharan 
Africa, North Africa, the Arabian Peninsula, the Comoros, Kenya, 
Somalia, the United Republic of Tanzania, Mayotte, Madagascar, 
Saudi Arabia and Yemen from 1997 to 2008.5,12-20 
During 2008 a re-emergence of RVF in South Africa was observed, 
with several focal outbreaks affecting livestock and humans across 
five provinces (Eastern Cape, Gauteng, Limpopo, Mpumalanga 
and North West). RVFV infection was confirmed in animals by the 
Agriculture Research Council-Onderstepoort Veterinary Institute 
(ARC-OVI) and the University of Pretoria. We report the subsequent 
outbreak of RVF in dairy farmers and farm workers, and the staff 
and students of a veterinary school. We investigated the prevalence of 
RVFV infection among them, their clinical presentation, and the risk 
factors associated with infection.
Methods
We conducted a cross-sectional serological survey of the exposed 
staff complement of farmers and farm workers from dairy farms with 
confirmed RVF in animals, and veterinary school staff and students 
exposed to carcasses and tissues of infected animals. Participants 
were examined to determine the presence of current or recent illness 
with symptoms compatible with RVFV infection. The suspect case 
definition included any person presenting with influenza-like illness 
(including fever ≥38°C, myalgia or headache), or any illness with Corresponding author: B N Archer (bretta@nicd.ac.za)
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Background. During 2008, Rift Valley fever (RVF) virus re-emerged 
in South Africa as focal outbreaks in several provinces. 
Aims. To investigate an outbreak affecting cattle farmers and farm 
workers, and the staff and students of a veterinary school, assess the 
prevalence of infection during the outbreak, document the clinical 
presentation of cases, and identify potential risk factors. 
Methods. We conducted a cross-sectional serological survey of 
exposed veterinarians and farmers, who were examined to determine 
the presence of current or recent illness. Blood specimens were 
collected for virus isolation, nucleic acid detection and serology. 
A subset was interviewed using a standardised questionnaire to 
obtain data on recent exposures and risk factors for infection. 
Results. Of 53 participants potentially exposed to infected 
domestic ruminants, 15% had evidence of recent infection and 4% 
evidence of past exposure to the RVF virus. The prevalence of acute 
infection was 21% in veterinarians compared with 9% in farmers 
and farm workers. After a mean incubation period of 4.3 days, the 
most frequent symptoms experienced included myalgia (100%), 
headache (88%) and malaise (75%). No asymptomatic cases were 
identified. Transmission by direct contact with infected animals 
was the major risk factor in these professional groups. Performing 
animal autopsies was significantly associated with acute infection 
(risk ratio 16.3, 95% confidence interval 2.3 - 114.2). 
Conclusions. Increased risks associated with veterinary practices 
highlight a need for the use of personal protective equipment, 
and identify veterinarians as a primary target group for future 
vaccination. 
S Afr Med J 2011;101:263-266.
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features of fever with encephalitis, haemorrhage, hepatitis or ocular 
pathology, with onset of illness after the date of exposure to the 
affected animals. 
Blood specimens were collected from all participants regardless 
of illness status for laboratory analysis by the National Institute for 
Communicable Diseases (NICD) of the National Health Laboratory 
Service (NHLS). To differentiate acute infection, non-infected, 
and persons with a past immunising event (previous infection or 
vaccination), RVF IgG and IgM enzyme-linked immunosorbent 
assay (ELISA) were performed.21 Additional tests included nucleic 
acid detection (an RVFV real-time reverse transcription polymerase 
chain reaction (PCR) and/or loop-mediated isothermal amplification 
assay) and/or virus isolation.22 A confirmed case was defined as 
any individual with a positive IgM, nucleic acid detection and/
or virus isolation result. Blood specimens were collected from 
hospitalised patients, analysed by a private pathology service to 
measure liver function, enzyme, protein and haematology levels and 
compared against standard haematology and biochemistry reference 
intervals.23 
A subset of the two occupational groups was interviewed using 
a standardised questionnaire for data on recent exposures and risk 
factors for infection. This included all participants meeting the 
confirmed case definition (acute infection), and a convenience sample 
of exposed individuals without documented illness (non-infected), 
excluding individuals with a laboratory-proven past immunising 
event, from the same occupational group. Data from completed 
questionnaires and laboratory results were captured and analysed 
using Epi Info 2000 (version 3.5.1, Centers for Disease Control and 
Prevention, Atlanta). Risk ratios (RRs) were calculated to compare 
infected and non-infected cases, and a chi-square test was performed 
with p-values <0.05 considered significant.
Ethics clearance for essential communicable disease surveillance 
was granted to the NICD by the Human Medical Research Ethics 
Committee of the University of the Witwatersrand, Johannesburg 
(protocol number M060449, reference R14/49 Schoub). This includes 
outbreak investigations related to notifiable medical conditions under 
surveillance, including RVF. 
Results
A total of 53 participants from the exposed groups were surveyed, 
including a complete staff complement of 22 dairy farm workers 
and 31 veterinary school staff and students. Of these, 30% (nfarm=7 
and nschool=9) met the suspect case defection – presenting with 
illness compatible with RVFV infection. Of 53 blood specimens, 
15% (nfarm=2 and nschool=6) were confirmed as having an acute 
RVFV infection. In 4% (nschool=2), anti-RVFV IgG was detected in 
the absence of anti-RVFV IgM; they were therefore classified as 
previously immunised, but we could not determine whether this 
was due to prior RVFV exposure or vaccination. Excluding the non-
susceptible individuals, the attack rate of RVFV infection was 16% 
(8/51) in the total population surveyed, 9% (2/22) in the dairy farm 
group, and 21% (6/29) in the veterinary school group.
Of the 8 laboratory-confirmed cases, 4 were aged 20 - 29 years and 
5 were male; 4 were diagnosed by detection of anti-RVFV IgM alone, 
3 by PCR and virus isolation, and 1 by PCR alone. Onset of illness of 
the two farmers was 2 and 8 days respectively after contact with sick 
or dead calves; however, timing of exposure may have varied (Fig. 1). 
The date of conducting the animal autopsies, and therefore exposure, 
was known for the veterinary school group and a mean incubation 
period of 4.3 days (range 4 - 5 days) could be calculated. 
All participants with laboratory evidence of recent viral infection 
were symptomatic and met the suspect case definition criteria. 
The most frequently reported symptoms included myalgia (8/8, 
100%), headache (7/8, 88%) and malaise (6/8, 75%), and 63% 
(5/8) were pyrexial (Table I). Four (50%) of the confirmed cases 
required hospitalisation, and RVF-associated encephalitis developed 
in 1 patient (13%) approximately a week after the acute episode. The 
immunological response of the 4 hospitalised cases, measured during 
the acute episode (Table II), showed raised levels of C-reactive protein 
(CRP), aspartate transaminase (AST) and alanine transminase (ALT). 
Three of the 4 patients had raised neutrophil granulocytes and 
decreased lymphocyte counts. Total white blood cell and platelet 
counts were normal among all 4 patients.
The 8 confirmed cases and an additional 22 susceptible, non-
immune individuals from the two groups were interviewed. All 
confirmed cases had direct contact with either sick or dead cattle 
(Table III), and there was a statistically significant association 
between performing an animal autopsy and acute infection (RR 16.3, 
95% confidence interval 2.3 - 114.2). None of the other risk factors 
considered were significant.
Figure and figure legend 
 
Fig. 1. Epidemic curve illustrating the frequency of confirmed Rift Valley fever cases by date of 
illness onset, dates of cattle deaths and exposure, and dates of investigation, Rift Valley fever 
outbreak, South Africa, 2008. 
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Fig. 1. Epidemic curve illustrating the frequency of confirmed Rift Valley fe-
ver cases by date of illness onset, dates of cattle deaths and exposure, and 
dates of investigation, Rift Valley fever outbreak, South Africa, 2008.
Table I. Frequency of symptoms and signs among 8 patients 
with confirmed Rift Valley fever virus infection in South 
Africa, 2008
Symptom Frequency (N (%)) 
Myalgia   8 (100)
Headache 7 (88)
Malaise 6 (75)
Pyrexia (>38°C) 5 (63)
Nausea 5 (63)
Dizziness 5 (63)
Abdominal pain 3 (38)
Rigors 3 (38)
Vomiting 2 (25)
Hyperaesthesia 1 (13)
Diarrhoea                        0 (0)
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Discussion
We documented an occupationally linked outbreak of RVF in farming 
and veterinary professionals coinciding with the re-emergence of 
RVF in South Africa after an extended inter-epizootic period. The 
8 confirmed human cases in the two occupational groups surveyed 
suggest that exposure to either sick or dead cattle was the major route 
of transmission. We noted an elevated attack rate and a significantly 
increased risk of infection among veterinarians who performed 
autopsies. Inadequate use of personal protective equipment, and use 
of high-pressure water jets to clean equipment and surfaces during 
animal autopsies, may have contributed to an increased risk among 
veterinarians by direct contact with infected tissues, or exposure to 
infectious aerosolised body fluids. 
After a mean incubation period of 4.3 days, confirmed cases 
presented with symptoms of myalgia, headache and malaise. Pyrexia 
was documented in roughly half of the patients; however, this may be 
understated owing to late measurement of body temperature in non-
hospitalised patients. Haematological and biochemical investigations 
on hospitalised patients all showed raised levels of CRP, AST and 
ALT, indicating inflammation and acute liver damage in more 
severely ill patients. Serological investigations revealed an additional 
2 participants with a previous immunising event; however, no 
asymptomatic acute infections were found, in contrast to the common 
occurrence of asymptomatic infection observed elsewhere.5 
Our findings, and specifically the risk factor analysis, may be 
limited in power by the few study participants. Secondly, demographic 
characteristics were not available for the proportion of the surveyed 
population excluded from in-depth interviews (non-respondents), 
prohibiting comparisons with the respondent group to exclude 
differences that may introduce bias.
Despite these limitations, this epizootic highlights the need for 
renewed vaccinations of ruminants against RVFV in South Africa. 
Increased risks of infection associated with veterinary practices 
emphasise the need for improved use of personal protective equipment 
and other preventive measures, especially while performing animal 
autopsies. This occupational group should also be considered as a 
primary target for future immunisation against RVF once human 
vaccines become available. Further strengthening of surveillance and 
intersectoral collaboration between the health and agriculture sectors 
will assist in rapid recognition and response to future outbreaks. 
The authors acknowledge members of the Outbreak Response Unit, the 
South African Field Epidemiology and Laboratory Training Programme 
(SA-FELTP), and the technical team of the Special Pathogens Unit, 
Table II. Measured liver function and haematological values and enzyme and protein levels in blood specimens from 4 hospitalised 
confirmed Rift Valley fever cases during acute-stage infection: Rift Valley fever outbreak, South Africa, 2008
RVF cases
Reference intervals† A B C D
C-reactive protein (mg/l) <8 36 46.1 45.6 -
Aspartate transaminase (IU/l) 3 - 35 107 93 94 82
Alanine transminase (IU/l) 3 - 35 62 141 80 67
Total white blood cell count (WCC) (×109/l) 4 -1 1 5.31 3.72 5.25 2.51
Neutrophil granulocytes (% WCC) 40 - 75 81 78.7 91.4 62
Lymphocyte (% WCC) 20 - 45 8.5 10.9 5.6 25
Platelet count (×109/l) 150 - 400 214 157 226 140
Total/direct bilirubin (μmol/l) 3 - 17/1.7 - 5.1 15/2 22/5 28/3 -
†Haematology and biochemistry reference intervals may vary depending on age, gender, race, measurement instruments and laboratory methodology.23
Table III. Analysis of risk factors among exposed populations during an outbreak of Rift Valley fever in South Africa, 2008
Exposure/risk factor
Confirmed acute cases, 
N=8 (N (%))
Non-infected,
N=22 (N (%)) RR 95% CI
Direct contact with sick/dead cattle 8 (100) 6 (27) - -
Performed autopsy 7 (88) 2 (9) 16.3 2.3 - 114.2
Disposed of carcass 4 (50) 8 (36) 1.5 0.5 - 4.9
Slaughtered an animal 1 (13) 3 (14) 0.9 0.2 - 5.7
Disposed of aborted fetus 2 (25) 7 (32) 0.8 0.2 - 3.1
Handled raw meat 1 (13) 11 (50) 0.2 <0.1-1.5
Skinned an animal 0 (0) 2 (9) - -
Consumed unpasteurised milk 0 (0) 0 (0) - -
Consumed raw meat 0 (0) 0 (0) - -
RR = risk ratio; CI = confidence interval.
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NICD-NHLS; public health registrars at the University of Witwatersrand; 
the Department of Veterinary Tropical Diseases, University of Pretoria, 
and ARC-OVI (for providing results of animal testing and participating 
in the outbreak investigation); Lancet Laboratories (for supplying 
haematological and biochemical data on hospitalised patients); and the 
South African Department of Health and the Department of Agriculture, 
Forestry, and Fisheries.   
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Are you a doctor, nurse or pharmacist?
Do you need clinical assistance with the treatment of your 
HIV or TB patients?
Contact the TOLL-FREE National HIV & TB Health Care Worker Hotline 0800 212 506/021 406 6782
Alternatively send an SMS or ‘Please Call Me’ to 071 840 1572
www.hivhotline.uct.ac.za
Call us – we will gladly assist you! This service is free.
The Medicines Information Centre (MIC), situated within the Division of Clinical Pharmacology, Department of Medicine, University of 
Cape Town, is the largest and only clinically based medicine information centre in South Africa.
In collaboration with the Foundation for Professional Development and USAID/PEPFAR, the MIC provides a toll-free national HIV and 
TB hotline to all health care workers in South Africa for patient treatment-related enquiries.
